Trinity Legacy Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Trinity Legacy Partners's LLY Position: Q1 2026 in Review
Trinity Legacy Partners increased its Eli Lilly (LLY) stake by 4.2% in Q1 2026, buying an estimated $139K and bringing the position to 3,397 shares worth $3.13M. The position accounts for 0.68% of the portfolio, ranked #54.
Trinity Legacy Partners first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.5M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Trinity Legacy Partners held 3,397 shares of Eli Lilly worth $3.13M as of Q1 2026.
- Trinity Legacy Partners bought 137 Eli Lilly shares in Q1 2026, an estimated $139K.
- Eli Lilly made up 0.68% of Trinity Legacy Partners's portfolio in Q1 2026, its #54 holding.
- Trinity Legacy Partners first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
- Trinity Legacy Partners's Eli Lilly position peaked at $3.5M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Trinity Legacy Partners's 13F filing for Q1 2026, filed 16 Apr 2026.